Evidence map›Paper›PMID 36927203›Full record

ArticlePublic health reports (Washington, D.C. : 1974)

Variation in State-Level Mammography Use, 2012 and 2020.

David H Howard, Florence K L Tangka, Jacqueline Miller, Susan A Sabatino

Abstract read
In one paragraph

Article in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Use of Cancer Screening Tests, United States, 2023.Preventing chronic disease · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David H HowardDepartment of Health Policy and Management, Winship Cancer Center, Emory University, Atlanta, GA, USA.ORCID 0000-0002-4465-0414
Florence K L TangkaDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Jacqueline MillerDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Susan A SabatinoDivision of Cancer Prevention and Control, Centers for Disease Control and Prevention, Atlanta, GA, USA.

Funding

CDC HHS 16IPA1604432
6 · The paper itself

Abstract

objectivesMammography is a screening tool for early detection of breast cancer. Uptake in screening use in states can be influenced by Medicaid coverage and eligibility policies, public health outreach efforts, and the Centers for Disease Control and Prevention-funded National Breast and Cervical Cancer Early Detection Program. We described state-specific mammography use in 2020 and changes as compared with 2012.

methodsWe estimated the proportion of women aged ≥40 years who reported receiving a mammogram in the past 2 years, by age group, state, and demographic and socioeconomic characteristics, using 2020 Behavioral Risk Factor Surveillance System data. We also compared 2020 state estimates with 2012 estimates.

resultsThe proportion of women aged 50-74 years who received a mammogram in the past 2 years was 78.1% (95% CI, 77.4%-78.8%) in 2020. Across measures of socioeconomic status, mammography use was generally lower among women who did not have health insurance (52.0%; 95% CI, 48.3%-55.6%) than among those who did (79.9%; 95% CI, 79.3%-80.6%) and among those who had a usual source of care (49.4%; 95% CI, 46.1%-52.7%) than among those who did not (81.0%; 95% CI, 80.4%-81.7%). Among women aged 50-74 years, mammography use varied across states, from a low of 65.2% (95% CI, 61.4%-69.0%) in Wyoming to a high of 86.1% (95% CI, 83.8%-88.3%) in Massachusetts. Four states had significant increases in mammography use from 2012 to 2020, and 8 states had significant declines.

conclusionMammography use varied widely among states. Use of evidence-based interventions tailored to the needs of local populations and communities may help close gaps in the use of mammography.

Indexed as

Breast NeoplasmsEarly Detection of CancerFemaleHumansInsurance, HealthMammographyMass ScreeningMedicaidUnited Statesbreast neoplasmsearly detection of cancerhealth behaviormammographysocioeconomic factorsstate governmentsurveys and questionnaires

Identifiers

PMID36927203
PMCPMC10905756

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.